177 related articles for article (PubMed ID: 3026016)
41. Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
Henri A; Klastersky J
Chemotherapy; 1974; 20(2):102-12. PubMed ID: 4367636
[No Abstract] [Full Text] [Related]
42. Sulbactam/ampicillin in paediatric infections.
Dajani AS
Drugs; 1988; 35 Suppl 7():35-8. PubMed ID: 3065053
[TBL] [Abstract][Full Text] [Related]
43. Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):939-42. PubMed ID: 3032552
[TBL] [Abstract][Full Text] [Related]
44. A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children.
Foster MC; Kapila L; Morris DL; Slack RC
Rev Infect Dis; 1986; 8 Suppl 5():S634-8. PubMed ID: 3026017
[TBL] [Abstract][Full Text] [Related]
45. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].
Hattori K; Higashino H; Kobayashi T; Yamamoto C; Nobori U; Nakamura Y; Satou Y; Kurokawa H; Nogi S; Kobayashi Y
Jpn J Antibiot; 1989 Mar; 42(3):701-17. PubMed ID: 2746850
[TBL] [Abstract][Full Text] [Related]
46. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
[TBL] [Abstract][Full Text] [Related]
47. [Studies on sulbactam/ampicillin in the field of pediatrics].
Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
[TBL] [Abstract][Full Text] [Related]
48. [Clinical efficacy of sulbactam/ampicillin in the field of pediatrics].
Ogura H; Hisakawa H; Kawakubo K; Kubota H; Shimanouchi Y; Matsumoto K; Tomoda T; Tone Y; Kurashige T
Jpn J Antibiot; 1989 Mar; 42(3):766-72. PubMed ID: 2746856
[TBL] [Abstract][Full Text] [Related]
49. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.
Carmeli Y; Castro J; Eliopoulos GM; Samore MH
Antimicrob Agents Chemother; 2001 Jan; 45(1):275-9. PubMed ID: 11120977
[TBL] [Abstract][Full Text] [Related]
50. Treatment of infections due to multiresistant Neisseria gonorrhoeae with sulbactam/ampicillin.
Kim JH; Choi KH; Kim YT; Yang IS
Rev Infect Dis; 1986; 8 Suppl 5():S599-603. PubMed ID: 3026010
[TBL] [Abstract][Full Text] [Related]
51. [Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics].
Hayashi M; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1989 Mar; 42(3):743-53. PubMed ID: 2746854
[TBL] [Abstract][Full Text] [Related]
52. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
[TBL] [Abstract][Full Text] [Related]
53. Treatment of ampicillin-resistant acute otitis media in the chinchilla.
Reilly JS; Doyle WJ; Cantekin EI; Supance JS; Kim HK; Rohn DD; Bluestone CD
Arch Otolaryngol; 1983 Aug; 109(8):533-5. PubMed ID: 6307238
[TBL] [Abstract][Full Text] [Related]
54. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
[TBL] [Abstract][Full Text] [Related]
55. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
56. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
57. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
Güneren MF
Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
[TBL] [Abstract][Full Text] [Related]
58. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Stromberg BV; Reines HD; Hunt P
Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
[TBL] [Abstract][Full Text] [Related]
59. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
60. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
Rev Infect Dis; 1986; 8 Suppl 5():S465-650. PubMed ID: 3025995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
